Amneal Pharmaceuticals (Germany) Analysis

Amneal Stock Analysis Notes

About 68.0% of the company shares are owned by institutions such as pension funds. The company has Price-to-Book (P/B) ratio of 1.17. In the past many companies with similar price-to-book ratios have beat the market. Amneal Pharmaceuticals recorded a loss per share of 0.73. The entity had not issued any dividends in recent years. Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey. AMNEAL PHMCTCLS operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6000 people. For more info on Amneal Pharmaceuticals please contact Chintu Patel at 908 947 3120 or go to https://www.amneal.com.

Amneal Pharmaceuticals Investment Alerts

Amneal Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 712.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amneal Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Amneal Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Amneal Profitablity

The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Technical Drivers

As of the 20th of December, Amneal Pharmaceuticals shows the Downside Deviation of 2.95, risk adjusted performance of 0.0245, and Mean Deviation of 2.31. Amneal Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Amneal Pharmaceuticals downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Amneal Pharmaceuticals is priced correctly, providing market reflects its regular price of 7.3 per share.

Amneal Pharmaceuticals Price Movement Analysis

Amneal Pharmaceuticals Outstanding Bonds

Amneal Pharmaceuticals Predictive Daily Indicators

Amneal Pharmaceuticals Forecast Models

Amneal Pharmaceuticals' time-series forecasting models are one of many Amneal Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amneal Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Amneal Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amneal shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Amneal Pharmaceuticals. By using and applying Amneal Stock analysis, traders can create a robust methodology for identifying Amneal entry and exit points for their positions.

When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.